Food Factors with Glucagon-Like Peptide-1 Release Activity Improve Glucose Tolerance

The GLP-1 opportunity

If your product targets post-meal glucose or satiety, you need to know about GLP-1. This gut hormone goes to work when food enters the intestine. This paper looked at food factors that trigger GLP-1 release and whether they improve glucose tolerance. Two ingredients stand out: D-allulose and resistant maltodextrin.

Background

GLP-1 is released from enteroendocrine L cells in response to meal ingestion. It is part of the body’s natural meal-handling system. Many processed foods pass through the gut with little hormonal feedback. That makes GLP-1-releasing food factors commercially interesting for formulators.

What the paper covers

The paper summarizes evidence on GLP-1-releasing food factors, with a focus on D-allulose and resistant maltodextrin. D-allulose is a non-metabolizable saccharide. It does not behave like a typical sugar. The evidence covers how oral D-allulose changes GLP-1 release and feeding behavior in rodents. It also covers resistant maltodextrin under continuous feeding conditions.

Key findings

D-allulose triggered GLP-1 secretion in two rodent models. That release had functional consequences. When mice received oral D-allulose, the rise in GLP-1 suppressed overeating and hyperglycemia. The animals ate less and handled glucose better.

The D-allulose effect was specific. It stimulated GLP-1 secretion but did not change GIP secretion. That is a meaningful difference. GIP is another incretin hormone, but its metabolic role is not identical to GLP-1. A food ingredient that selectively activates GLP-1 may be easier to position for weight management and diabetes prevention.

Resistant maltodextrin worked through a different pattern. Continuous feeding of RMD increased plasma GLP-1 in normal rats and in rats on a high-fat/high-sucrose diet—two distinct dietary conditions. The GLP-1 increase came alongside higher short-chain fatty acid production. That points to a gut-fermentation route.

| Food factor | GLP-1 effect | GIP effect | Other observations | | D-allulose | Promotes GLP-1 release in rats and mice | No effect on GIP secretion | Oral intake suppressed overeating and hyperglycemia in mice | | Resistant maltodextrin | Raises plasma GLP-1 in normal and high-fat/high-sucrose rats | Not reported in the evidence | Continuous feeding increases short-chain fatty acid production |

What this means for manufacturers

D-allulose has a rare combination of properties. It is not metabolized, and it triggers GLP-1. That gives formulators a reason to look beyond simple sugar replacement. A product built around D-allulose could support glucose tolerance and appetite control without relying on drugs.

The GIP finding adds another layer. Many ingredients affect multiple incretin pathways. D-allulose appears to stay focused on GLP-1. That focused mechanism is attractive for product positioning and future development.

Resistant maltodextrin is a different tool. It is a fiber-type ingredient that works through fermentation. The SCFA connection makes it useful in digestive health products, and the GLP-1 effect adds a metabolic health angle. For formulators, RMD may fit a fiber matrix better than a sweetener system.

Would the two ingredients work together? This evidence does not test that combination. You would need your own data before making a combination claim.

FAQ

Does D-allulose affect GIP?

No. In this evidence, D-allulose induced GLP-1 secretion without affecting GIP. That selectivity is one reason it draws attention for obesity and diabetes applications.

Is resistant maltodextrin an alternative to D-allulose?

It depends on the application. RMD raised plasma GLP-1 in rats on normal and high-fat/high-sucrose diets, but the effect appeared with continuous feeding and was linked to short-chain fatty acid production. It is not a sweetener. Use it where fiber and fermentation fit.

Can these ingredients replace GLP-1 drugs?

No. These are food factors, not pharmaceuticals. The data come from rodent models. They are useful for product development, but any commercial claims must stay within food regulatory frameworks.

The GLP-1 field is moving quickly. Ingredients that trigger this hormone naturally will find their way into more products. D-allulose is the clear sugar-replacement option. RMD is a solid fiber-based route. Both deserve attention in your next metabolic health formulation.